VIMTALABSNSEVimta Labs Limited· PharmaceuticalsHighPositive
Announced Thu, 15 May · 17:10 IST

Vimta Labs Limited has informed the Exchange that Record date for the purpose of Dividend is 30-May-2025.

Bonus Above 1to1Corporate Actions View source PDF

VIMTALABS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Vimta Labs has fixed 30 May 2025 as the record date for a ₹2 per equity share dividend for FY25, subject to shareholder approval at the 35th AGM on 6 June 2025 (held via video conferencing). The AGM notice also seeks approval for a 1:1 bonus share issue (1 bonus share for every 1 held), an increase in the overall borrowing limit to ₹300 crores, and a strategic entry into the Biologics Contract Research and Development (CDMO) segment with an estimated ₹50 crore investment. Other agenda items include appointment of a secretarial auditor, re-appointment of an independent director, revision of remuneration for executive directors, and ratification of cost auditor fees. Dividend payment, if approved, is scheduled for 16 June 2025.

Likely market impact

The combined ₹2 dividend and 1:1 bonus is shareholder-friendly, but the bonus will double the share count and proportionally halve per-share metrics like EPS and per-share dividend. The proposed Biologics CDMO foray signals long-term growth ambitions and could unlock new revenue, though it will raise capital requirements. Investors should track AGM voting outcomes and the post-bonus ex-date price adjustment.